Nuvation Bio Inc.
DIARYLHYDANTOIN COMPOUNDS AND METHODS OF USE THEREOF
Last updated:
Abstract:
The disclosure relates to anti-cancer compounds derived from nuclear steroid receptor binders, to products containing the same, as well as to methods of their use and preparation.
Status:
Application
Type:
Utility
Filling date:
27 Nov 2019
Issue date:
25 Jun 2020